SCHEMBL23229346

SCHEMBL23229346

Cc1ccc2ccc(N(C)C)nc2c1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NCF1 P14598 1/20 0.59
▸ CYP1A2 P05177 4/20 0.57
▸ ALDH1A1 P00352 6/20 0.49
▸ KDM4E B2RXH2 2/20 0.49
▸ GAA P10253 2/20 0.49
▸ CYP2A6 P11509 3/20 0.42
▸ NQO2 P16083 1/20 0.42
▸ TERT O14746 1/20 0.42
▸ APP P05067 1/20 0.42
▸ LMNA P02545 2/20 0.41
▸ MAPT P10636 2/20 0.41
▸ KMT2A Q03164 2/20 0.41
▸ NPSR1 Q6W5P4 1/20 0.41
▸ ESR1 P03372 1/20 0.40
▸ MEN1 O00255 1/20 0.39
▸ NCK1 P16333 1/20 0.38
▸ BACE1 P56817 1/20 0.38
▸ POLB P06746 1/20 0.38
▸ TP53 P04637 1/20 0.37
▸ SMN1; SMN2 Q16637 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8275784 0.86 CYP1A2 (0.59) NCF1CYP1A2ALDH1A1KDM4EGAA
SCHEMBL31143623 0.86 CYP1A2 (0.59) NCF1CYP1A2ALDH1A1KDM4EGAA
SCHEMBL31366067 0.78 NCF1 (0.57) NCF1CYP1A2ALDH1A1KDM4ETERT
SCHEMBL22059366 0.75 NQO2 (0.47) NCF1CYP1A2ALDH1A1KDM4EGAA
SCHEMBL4263734 0.74 NCF1 (1.00) NCF1CYP1A2ALDH1A1KDM4ELMNA
SCHEMBL29946313 0.74 NCF1 (1.00) NCF1CYP1A2ALDH1A1KDM4ELMNA
SCHEMBL31650826 0.74 NCF1 (1.00) NCF1CYP1A2ALDH1A1KDM4ELMNA
SCHEMBL20008616 0.73 TERT (0.80) CYP1A2ALDH1A1KDM4EGAACYP2A6
SCHEMBL31261751 0.73 CYP1A2 (1.00) CYP1A2ALDH1A1KDM4ECYP2A6NQO2
SCHEMBL30081469 0.73 CYP1A2 (1.00) CYP1A2ALDH1A1KDM4ECYP2A6NQO2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210107908-A1 PHARMACEUTICAL COMPOUNDS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2021-04-15 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210107908-A1 PHARMACEUTICAL COMPOUNDS MAPT, CYP3A5, SLC5A1 NCF1 3920/4885CYP1A2 191/4885ALDH1A1 703/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback